title: Breathlessness, night sweats, and weight loss on natalizumab.
authors.forename: D
authors.initials: D
authors.lastname: Dahdaleh
authors.forename: D M
authors.initials: DM
authors.lastname: Altmann
authors.forename: O
authors.initials: O
authors.lastname: Malik
authors.forename: R S
authors.initials: RS
authors.lastname: Nicholas
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D004417:Dyspnea / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D000069442:Natalizumab; D009894:Opportunistic Infections / Q000139:chemically induced; D010996:Pleural Effusion / Q000139:chemically induced / Q000382:microbiology; D013546:Sweating / Q000187:drug effects*; D014397:Tuberculosis, Pulmonary / Q000139:chemically induced; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000069442:Natalizumab